Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Jannis Kountouras^{1

2}, Apostolis Papaefthymiou^{3

4

5}, Stergios A Polyzos⁵, Christos Liatsos⁶, Maria Tzitiridou-Chatzopoulou^{3

7}, Dimitrios Chatzopoulos³, Elisabeth Vardaka^{3

8}, Dimitra Gialamprinou⁹, Georgios Kotronis¹⁰, Tharshika Thavayogarajah¹¹, Michael Doulberis^{3

5

12

13}

Affiliations

¹ Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, 54642, Thessaloniki, Macedonia, Greece. jannis@auth.gr.
² , 8 Fanariou St, Byzantio, 551 33, Thessaloniki, Macedonia, Greece. jannis@auth.gr.
³ Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, 54642, Thessaloniki, Macedonia, Greece.
⁴ Department of Gastroenterology, University Hospital of Larisa, 41110, Larisa, Greece.
⁵ First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Macedonia, Greece.
⁶ Department of Gastroenterology, 401 General Military Hospital of Athens, 54124, Attiki, Greece.
⁷ School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Koila, 50100, Kozani, Macedonia, Greece.
⁸ Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Alexander Campus, 57400, Thessaloniki, Macedonia, Greece.
⁹ Second Neonatal Department and NICU, Aristotle University of Thessaloniki, Papageorgiou General Hospital, 56403, Thessaloniki, Macedonia, Greece.
¹⁰ Department of Internal Medicine, General Hospital Aghios Pavlos of Thessaloniki, 55134, Thessaloniki, Macedonia, Greece.
¹¹ Department of Medical Oncology and Hematology, University Hospital and University of Zurich, 8091, Zurich, Switzerland.
¹² Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, 5001, Aarau, Switzerland.
¹³ Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.

PMID: 35930122
DOI: 10.1007/s10620-022-07642-1

Comment

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Jannis Kountouras et al. Dig Dis Sci. 2023 Feb.

. 2023 Feb;68(2):701-702.

doi: 10.1007/s10620-022-07642-1. Epub 2022 Aug 5.

Authors

Affiliations

¹ Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, 54642, Thessaloniki, Macedonia, Greece. jannis@auth.gr.
² , 8 Fanariou St, Byzantio, 551 33, Thessaloniki, Macedonia, Greece. jannis@auth.gr.
³ Second Medical Clinic, School of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, 54642, Thessaloniki, Macedonia, Greece.
⁴ Department of Gastroenterology, University Hospital of Larisa, 41110, Larisa, Greece.
⁵ First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, 54124, Thessaloniki, Macedonia, Greece.
⁶ Department of Gastroenterology, 401 General Military Hospital of Athens, 54124, Attiki, Greece.
⁷ School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Koila, 50100, Kozani, Macedonia, Greece.
⁸ Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Alexander Campus, 57400, Thessaloniki, Macedonia, Greece.
⁹ Second Neonatal Department and NICU, Aristotle University of Thessaloniki, Papageorgiou General Hospital, 56403, Thessaloniki, Macedonia, Greece.
¹⁰ Department of Internal Medicine, General Hospital Aghios Pavlos of Thessaloniki, 55134, Thessaloniki, Macedonia, Greece.
¹¹ Department of Medical Oncology and Hematology, University Hospital and University of Zurich, 8091, Zurich, Switzerland.
¹² Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, 5001, Aarau, Switzerland.
¹³ Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.

PMID: 35930122
DOI: 10.1007/s10620-022-07642-1

No abstract available

PubMed Disclaimer

Comment on

E-cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study.
Sheehan GT, Twardus SW, Cagan A, Ananthakrishnan AN. Sheehan GT, et al. Dig Dis Sci. 2023 Jan;68(1):208-213. doi: 10.1007/s10620-022-07539-z. Epub 2022 May 17. Dig Dis Sci. 2023. PMID: 35579793

References

1. Sheehan GT, Twardus SW, Cagan A, Ananthakrishnan AN. E-cigarette Use and Disease Outcomes in Inflammatory Bowel Diseases: A Case-Control Study. Dig Dis Sci. 2022. https://doi.org/10.1007/s10620-022-07539-z . - DOI
1. Sleutjes JAM, van Lennep JER, van der Woude CJ, de Vries AC. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol. 2021;14:17562848211032126. - DOI
1. Zhang XY, Dong HC, Wang WF, Zhang Y. Risk of venous thromboembolism in children and adolescents with inflammatory bowel disease: A systematic review and meta-analysis. World J Gastroenterol. 2022;28:1705–1717. - DOI
1. Tsiaousi E, Anastastiadou K, Michael S et al. Thrombophilia in patients with inflammatory bowel disease. Ann Gastroenterol. 2011;24:43 (in Greek)
1. Kountouras J, Polyzos SA, Katsinelos P et al. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy. Int J Cardiol. 2017;229:17–18. - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Affiliations

Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

LinkOut - more resources

Medical